牛牛AI助理已提取核心訊息
Arcutis Biotherapeutics, Inc. has filed a registration statement with the SEC for an at-the-market offering of common stock, aiming to raise up to $100 million. The shares will be sold through Cowen and Company, LLC, acting as the sales agent. The offering will be made under an amended and restated sales agreement, with shares sold at varying market prices. The proceeds are intended for general corporate purposes, continued product development, and commercial launch planning. The common stock is listed on the Nasdaq Global Select Market under the symbol 'ARQT'. The last reported sale price of Arcutis' common stock was $5.87 per share as of January 30, 2024. The offering's success and the actual number of shares sold will depend on market conditions.
Arcutis Biotherapeutics, Inc. has filed a registration statement with the SEC for an at-the-market offering of common stock, aiming to raise up to $100 million. The shares will be sold through Cowen and Company, LLC, acting as the sales agent. The offering will be made under an amended and restated sales agreement, with shares sold at varying market prices. The proceeds are intended for general corporate purposes, continued product development, and commercial launch planning. The common stock is listed on the Nasdaq Global Select Market under the symbol 'ARQT'. The last reported sale price of Arcutis' common stock was $5.87 per share as of January 30, 2024. The offering's success and the actual number of shares sold will depend on market conditions.
Arcutis Biotherapeutics, Inc.已向美國證券交易委員會提交了在市場上發行普通股的註冊聲明，旨在籌集高達1億美元的資金。這些股票將通過擔任銷售代理的Cowen and Company, LLC出售。此次發行將根據經修訂和重述的銷售協議進行，股票將以不同的市場價格出售。所得款項用於一般公司用途、持續的產品開發和商業發佈規劃。普通股在納斯達克全球精選市場上市，股票代碼爲 “ARQT”。截至2024年1月30日，上次公佈的Arcutis普通股銷售價格爲每股5.87美元。此次發行的成功和實際出售的股票數量將取決於市場狀況。
Arcutis Biotherapeutics, Inc.已向美國證券交易委員會提交了在市場上發行普通股的註冊聲明，旨在籌集高達1億美元的資金。這些股票將通過擔任銷售代理的Cowen and Company, LLC出售。此次發行將根據經修訂和重述的銷售協議進行，股票將以不同的市場價格出售。所得款項用於一般公司用途、持續的產品開發和商業發佈規劃。普通股在納斯達克全球精選市場上市，股票代碼爲 “ARQT”。截至2024年1月30日，上次公佈的Arcutis普通股銷售價格爲每股5.87美元。此次發行的成功和實際出售的股票數量將取決於市場狀況。
有用
沒用